🇺🇸 FDA

Drug profile · INN

rosuvastatin calcium

ROSUVASTATIN CALCIUM

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

rosuvastatin calcium (ROSUVASTATIN CALCIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN rosuvastatin calcium
Brand ROSUVASTATIN CALCIUM
Route ORAL
Formulation CAPSULE
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 7994178

    Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7396927

    Process for preparation of rosuvastatin calcium

    Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is rosuvastatin calcium?

rosuvastatin calcium (ROSUVASTATIN CALCIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for rosuvastatin calcium?

ROSUVASTATIN CALCIUM is a marketed brand name for rosuvastatin calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of rosuvastatin calcium?

rosuvastatin calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.